09
Jun
2014

VIDEO: Merck to Buy Idenix for $3.9B for Hepatitis C Drugs

June 9 (Bloomberg) — Merck & Co. agreed to buy Idenix Pharmaceuticals Inc. for about $3.85 billion to add experimental drugs to treat hepatitis C. Adam Johnson reports on Bloomberg Television’s “Bloomberg Surveillance.” (Source: Bloomberg)

[grabpress_video guid=42c24b9d7106e8ebfd4ee71df2b57d02cd8d42fa embed_id=2085735]

Thanks for checking us out. Please take a look at the rest of our videos and articles.

To stay in the loop, bookmark our homepage.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *